share_log

bluebird bio | 4: Statement of changes in beneficial ownership of securities-Director Cloonan Michael

bluebird bio | 4: Statement of changes in beneficial ownership of securities-Director Cloonan Michael

bluebird bio | 4:持股變動聲明-董事 Cloonan Michael
美股SEC公告 ·  06/24 17:21

Moomoo AI 已提取核心訊息

Michael Cloonan, associated with bluebird bio, Inc. [BLUE], was involved in a transaction on June 20, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. Investors are advised to await further information to fully understand the impact of this event on their investment decisions regarding bluebird bio stock.
Michael Cloonan, associated with bluebird bio, Inc. [BLUE], was involved in a transaction on June 20, 2024. The specific details of the transaction, including the action type, status, number of shares involved, nature of shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. Investors are advised to await further information to fully understand the impact of this event on their investment decisions regarding bluebird bio stock.
2024年6月20日,與bluebird bio,Inc. [BLUE]有關的Michael Cloonan參與了一項交易。公告中未披露交易的具體細節,包括操作類型、狀態幣、涉及的股份數量、股份性質、交易價格和交易後的參股金融。建議投資者等待進一步信息,以充分了解此事件對其關於bluebird bio股票的投資決策的影響。
2024年6月20日,與bluebird bio,Inc. [BLUE]有關的Michael Cloonan參與了一項交易。公告中未披露交易的具體細節,包括操作類型、狀態幣、涉及的股份數量、股份性質、交易價格和交易後的參股金融。建議投資者等待進一步信息,以充分了解此事件對其關於bluebird bio股票的投資決策的影響。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息